Catheter Precision (VTAK) Cash & Equivalents (2017 - 2026)

Catheter Precision (VTAK) has reported Cash & Equivalents for 10 consecutive years, with $643000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 23.27% year-over-year to $643000.0 in Q2 2026; TTM through Jun 2026 was $643000.0, a 23.27% decrease from a year earlier, with the FY2025 full-year figure at $88000.0, down 96.94% from the prior year.
• Cash & Equivalents was $643000.0 for Q2 2026 at Catheter Precision, up from $441000.0 in the prior quarter.
• Over five years, Cash & Equivalents peaked at $17.7 million in Q1 2022 and troughed at $16000.0 in Q2 2024.
• A 5-year average of $5.0 million and a median of $1.5 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 99.78% in 2024 and jumped 5137.5% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $15.9 million in 2022, then plunged by 77.52% to $3.6 million in 2023, then decreased by 19.41% to $2.9 million in 2024, then slumped by 96.94% to $88000.0 in 2025, then soared by 630.68% to $643000.0 in 2026.
• The last three Cash & Equivalents figures came in at $643000.0 (Q2 2026), $441000.0 (Q1 2026), and $88000.0 (Q4 2025), per Business Quant data.